Assessing a composite end point for new tocolytics in clinical trials: Data from 4 US integrated delivery networks

Purpose A composite end point (CE) measuring neonatal benefit was created for use in tocolytic randomized controlled trials with rates assessed using data from one referral hospital. The goal of this study was to assess wider generalizability of the CE, using data from multiple integrated delivery n...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2018-02, Vol.27 (2), p.213-220
Hauptverfasser:	Pimenta, Jeanne M., Brinkley, Emma, Montague, Timothy H., Beach, Kathleen J., Mack, Christina
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Clinical trials composite end point Delivery of Health Care, Integrated - statistics & numerical data Drug development Drug Development - methods Female Gestational Age Humans Infant, Extremely Premature Infant, Newborn Infants Integrated delivery systems neonatal Neonates Outcome Assessment (Health Care) - methods Outcome Assessment (Health Care) - statistics & numerical data pharmacoepidemiology Pregnancy Premature Birth - epidemiology Premature Birth - prevention & control Purchasing groups Randomization randomized controlled trials Randomized Controlled Trials as Topic Research Design retrospective data Retrospective Studies Sample Size tocolytic Tocolytic Agents - administration & dosage United States - epidemiology Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!